Overview
Jieti Medical is a company headquartered in Beijing, China.
Summary generated from the structured facts on this page.
Funding
Amounts as reported; USD estimates shown only when they matchListed 3 funding records. Latest funding: RMB 500M (Strategic), Mar 13, 2026.
1 listed record lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Jul 30, 2026 | Undisclosed · Equity | 北京榕升企业管理合伙企业（有限合伙）, 厦门瑞庭投资有限公司, 吉利共创贰拾肆号投资（天津）合伙企业（有限合伙）, 无锡鼎晖弘嘉股权投资合伙企业（有限合伙）, 深圳市达晨创程私募股权投资基金企业（有限合伙）, 温州源润极来创业投资合伙企业（有限合伙）, 苏州工业园区阶梯觉醒创业投资合伙企业（有限合伙）, 长三角创业投资引导基金合伙企业（有限合伙） | No source link |
Evidence Jieti Medical raises an undisclosed amount in equity financingOn 2026-07-30, according to Xiniu Data, Jieti Medical completed equity financing for an undisclosed amount. The company is a developer of implantable brain-computer interface technology. Translated source brief, not a quotation. Check the original before citing. Sources · 0
北京榕升企业管理合伙企业（有限合伙）, 厦门瑞庭投资有限公司, 吉利共创贰拾肆号投资（天津）合伙企业（有限合伙）, 无锡鼎晖弘嘉股权投资合伙企业（有限合伙）, 深圳市达晨创程私募股权投资基金企业（有限合伙）, 温州源润极来创业投资合伙企业（有限合伙）, 苏州工业园区阶梯觉醒创业投资合伙企业（有限合伙）, 长三角创业投资引导基金合伙企业（有限合伙） | |||
| Mar 13, 2026 | RMB 500M ≈ $71.4M · Strategic | Alibaba, OrbiMed, Qiming Venture Capital, 上海国投, 元禾原点, 国投创合, 源来资本, 源码资本, 潮汐资本, 礼来亚洲基金 | No source link |
Evidence Jieti Medical raises RMB 500 million in strategic financingOn 2026-03-13, according to Xiniu Data, Jieti Medical completed strategic financing, raising RMB 500 million. Investors were Yuanlai Capital, Yuanheyuandian, Qiming Venture Capital, OrbiMed and others. Translated source brief, not a quotation. Check the original before citing. | |||
| Feb 10, 2025 | RMB 350M ≈ $50M · Series B | OrbiMed, Qiming Venture Capital, 源来资本, 礼来亚洲基金 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 3 valuation records.
No chartable valuation estimates yet.
3 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Jul 30, 2026 | — · Equity | 北京榕升企业管理合伙企业（有限合伙）, 厦门瑞庭投资有限公司, 吉利共创贰拾肆号投资（天津）合伙企业（有限合伙）, 无锡鼎晖弘嘉股权投资合伙企业（有限合伙）, 深圳市达晨创程私募股权投资基金企业（有限合伙）, 温州源润极来创业投资合伙企业（有限合伙）, 苏州工业园区阶梯觉醒创业投资合伙企业（有限合伙）, 长三角创业投资引导基金合伙企业（有限合伙） | No source link |
Evidence Jieti Medical raises an undisclosed amount in equity financingOn 2026-07-30, according to Xiniu Data, Jieti Medical completed equity financing for an undisclosed amount. The company is a developer of implantable brain-computer interface technology. Translated source brief, not a quotation. Check the original before citing. Sources · 0
北京榕升企业管理合伙企业（有限合伙）, 厦门瑞庭投资有限公司, 吉利共创贰拾肆号投资（天津）合伙企业（有限合伙）, 无锡鼎晖弘嘉股权投资合伙企业（有限合伙）, 深圳市达晨创程私募股权投资基金企业（有限合伙）, 温州源润极来创业投资合伙企业（有限合伙）, 苏州工业园区阶梯觉醒创业投资合伙企业（有限合伙）, 长三角创业投资引导基金合伙企业（有限合伙） | |||
| Mar 13, 2026 | — · Strategic | Alibaba, OrbiMed, Qiming Venture Capital, 上海国投, 元禾原点, 国投创合, 源来资本, 源码资本, 潮汐资本, 礼来亚洲基金 | No source link |
Evidence Jieti Medical raises RMB 500 million in strategic financingOn 2026-03-13, according to Xiniu Data, Jieti Medical completed strategic financing, raising RMB 500 million. Investors were Yuanlai Capital, Yuanheyuandian, Qiming Venture Capital, OrbiMed and others. Translated source brief, not a quotation. Check the original before citing. | |||
| Feb 10, 2025 | — · Series B | OrbiMed, Qiming Venture Capital, 源来资本, 礼来亚洲基金 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.